Despite the success of combination antiretroviral therapies, people living with HIV (PLWH) are at an increased risk of developing diverse malignancies, including oral cancer. We here present two cases of PLWH where the early diagnosis of potentially malignant disorders in the oral cavity impacted their treatment and survival, remaining free of disease after their complete elimination. These cases demonstrate the importance of oral examinations and tissue biopsies as a part of the close monitoring of PLWH.
ChiuCGSmithDSaltersKAet al.
Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: implications for HAART use and NADM development. BMC Cancer2017;
17: 270.
2.
BeachlerDCAbrahamAGSilverbergMJet al.; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA.
Incidence and risk factors of HPV-related and HPV-unrelated head and neck squamous cell carcinoma in HIV-infected individuals. Oral Oncol2014;
50: 1169–1176.
3.
PurginaBPantanowitzLSeethalaRR.A review of carcinomas arising in the head and neck region in HIV-positive patients. Patholog Res Int2011;
469150: 1–12.
4.
MahalePEngelsEACoghillAEet al.
Cancer risk in older persons living with human immunodeficiency virus infection in the United States. Clin Infect Dis2018;
67: 50–57.
5.
TotaJEEngelsEAMadeleineMMet al.
Risk of oral tongue cancer among immunocompromised transplant recipients and human immunodeficiency virus-infected individuals in the United States. Cancer2018;
124: 2515–2522.
6.
BeachlerDCD’souzaG.Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals. Curr Opin Oncol2013;
25: 503–510.
7.
GillisonML.Oropharyngeal cancer: a potential consequence of concomitant HPV and HIV infection. Curr Opin Oncol2009;
21: 439–444.
8.
GaneshDSreenivasanPÖhmanJet al.
Potentially malignant oral disorders and cancer transformation. Anticancer Res2018;
38: 3223–3229.
9.
ShielsMSAlthoffKNPfeifferRMet al.;
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA). HIV infection, immunosuppression, and age at diagnosis of non-AIDS-defining cancers. Clin Infect Dis2017;
64: 468–475.
10.
PicardAArowasLPirothLet al.;
ORL-HIV-HPV study group. Head and neck squamous cell carcinoma in people living with HIV in France. Med Mal Infect2018;
17: 30875–30882.
11.
ZucchettoAVirdoneSTaborelliMet al.
Non-AIDS-defining cancer mortality: emerging patterns in the late HAART era. J Acquir Immune Defic Syndr2016;
73: 190–196.
12.
ChewEYHartmanCMRichardsonPAet al.
Risk factors for oropharynx cancer in a cohort of HIV-infected veterans. Oral Oncol2017;
68: 60–66.
13.
KesselringAGrasLSmitCet al.
Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy. Clin Infect Dis2011;
52: 1458–1465.
14.
VernonLTJayashanthaPChidzongaMMet al.
Comorbidities associated with HIV and antiretroviral therapy (clinical sciences): a workshop report. Oral Dis2016;
22: 135–148.
15.
Ramírez-AmadorVAnaya-SaavedraGCrabtree-RamírezBet al.
Clinical spectrum of oral secondary syphilis in HIV-infected patients. J Sex Transm Dis2013;
2013: 892427.
16.
BernsteinWBLittleRFWilsonWHet al.
Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy. Int J Hematol2006;
84: 3–11.
